The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development
Open accessAbstract
MicroRNAs (miRNAs) are endogenous short (approximately 22) nucleotide RNAs that regulate gene function by modification of target mRNAs. miRNA-1 (miR-1) and miRNA-206 (miR-206) are highly expressed in skeletal muscle. Due to the tissue-specific nature of miR-1/206 for skeletal muscles, we investigated the role of miR-1/206 in the development of rhabdomyosarcoma. Initially, we demonstrated that miR-1/206 expression was suppressed in rhabdomyosarcomas and found at very low levels in a rhabdomyosarcoma RD cell line. Transient transfection of miR-1/206 into cultured RD cells led to a significant decrease in cell growth and migration. Using bioinformatics, we identified two putative miR-1/206 binding sites within the 3'-untranslated region of the human c-Met mRNA. miR-1/206 was then shown to have activity on mRNA expression by targeting the c-Met 3'-untranslated region. The expression of c-Met protein was shown to be down-regulated by subsequent Western blot analysis. Conversely, up-regulation of c-Met was confirmed in tissue samples of human rhabdomyosarcoma, with its level inversely correlated with miR-1/206 expression. In vivo, miR-1/206-expressing tumor cells showed growth delay in comparison with negative control. Our results demonstrated that miR-1/206 suppressed c-Met expression in rhabdomyosarcoma and could function as a potent tumor suppressor in c-Met-overexpressing tumors. Inhibition of miR-1/206 function could contribute to aberrant cell proliferation and migration, leading to rhabdomyosarcoma development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nasser, M. W., Datta, J., Nuovo, G., Kutay, H., Motiwala, T., Majumder, S., Wang, B., Suster, S., Jacob, S. T., & Ghoshal, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804788200 · Cited by 360
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J.-F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2006) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,779
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Muscle-specific microRNA miR-206 promotes muscle differentiation
Kim, H. K., Lee, Y. S., Sivaprasad, U., Malhotra, A., & Dutta, A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200603008 · Cited by 766
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719
Naito, S., von Eschenbach, A. C., Giavazzi, R., & Fidler, I. J. (1986) · PubMed · Cited by 520
MicroRNA-206: The skeletal muscle-specific myomiR
MCCARTHY, J. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.03.001 · Cited by 422
Rhabdomyosarcoma in adults: A retrospective analysis of 171 patients treated at a single institution
Ferrari, A., Dileo, P., Casanova, M., Bertulli, R., Meazza, C., Gandola, L., Navarria, P., Collini, P., Gronchi, A., Olmi, P., et al. (2003) · Cancer · doi:10.1002/cncr.11550 · Cited by 403
MIR-206 regulates connexin43 expression during skeletal muscle development
Anderson, C., Catoe, H., & Werner, R. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl743 · Cited by 372
Pax3 modulates expression of the c-Met receptor during limb muscle development.
Epstein, J. A., Shapiro, D. N., Cheng, J., Lam, P. Y., & Maas, R. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4213 · Cited by 368
miR-206 Expression Is Down-regulated in Estrogen Receptor α–Positive Human Breast Cancer
Kondo, N., Toyama, T., Sugiura, H., Fujii, Y., & Yamashita, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0180 · Cited by 298
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Danilkovitch‐Miagkova, A., & Zbar, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15418 · Cited by 268
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Danilkovitch-Miagkova, A., & Zbar, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215418 · Cited by 244
Keller, C., Hansen, M. S., Coffin, C. M., & Capecchi, M. R. (2004) · Genes & Development · doi:10.1101/gad.1243904 · Cited by 235
MicroRNA expression signature of human sarcomas
Subramanian, S., Lui, W. O., Lee, C. H., Espinosa, I., Nielsen, T. O., Heinrich, M. C., Corless, C. L., Fire, A. Z., & van de Rijn, M. (2008) · Oncogene · doi:10.1038/sj.onc.1210836 · Cited by 230
Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis
Sharp, R., Recio, J. A., Jhappan, C., Otsuka, T., Liu, S., Yu, Y., Liu, W., Anver, M., Navid, F., Helman, L. J., et al. (2002) · Nature Medicine · doi:10.1038/nm787 · Cited by 158
Validation of Met as a Therapeutic Target in Alveolar and Embryonal Rhabdomyosarcoma
Taulli, R., Scuoppo, C., Bersani, F., Accornero, P., Forni, P. E., Miretti, S., Grinza, A., Allegra, P., Schmitt-Ney, M., Crepaldi, T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4292 · Cited by 155
The Met pathway: master switch and drug target in cancer progression
Mazzone, M., & Comoglio, P. M. (2006) · The FASEB Journal · doi:10.1096/fj.06-5947rev · Cited by 124
Ferracini, R., Olivero, M., Renzo, M. F. D., Martano, M., Giovanni, C. D., Nanni, P., Basso, G., Scotlandi, K., Lollini, P., & Comoglio, P. M. (1996) · PubMed · Cited by 122
Rhabdomyosarcoma: New Windows of Opportunity
Breitfeld, P. P., & Meyer, W. H. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-518 · Cited by 119
Ginsberg, J. P., Davis, R. J., Bennicelli, J. L., Nauta, L. E., & Barr, F. G. (1998) · PubMed · Cited by 103
Cited by
Satellite Cells and the Muscle Stem Cell Niche
Yin, H., Price, F., & Rudnicki, M. A. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2011 · Cited by 2,166
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Muscle-specific microRNAs in skeletal muscle development
Horak, M., Novak, J., & Bienertova-Vasku, J. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2015.12.013 · Cited by 478
MicroRNAs as Regulators of Differentiation and Cell Fate Decisions
Ivey, K. N., & Srivastava, D. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.012 · Cited by 449
miR-206 and -486 Induce Myoblast Differentiation by Downregulating Pax7
Dey, B. K., Gagan, J., & Dutta, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01009-10 · Cited by 408
Metadata
- Authors
- Yan, D., Dong, X. D., Chen, X., Wang, L., Lu, C., Wang, J., Qu, J., & Tu, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 284
- Issue
- 43
- Pages
- 29596-29604
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2089858439
- Cited by
- 271
- References
- 27
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.